InvestorsHub Logo

CPM

10/07/20 9:16 AM

#29528 RE: lazoom #29523

Actually, depends on the clone they are using. Clone 3 is broader spectrum and a lot less expensive to produce. Hence, why ENZC will climb to new heights and either provide a solution and make billions or get acquired. Again, there is too much value here. Onward and upward.

BluE33

10/07/20 9:16 AM

#29530 RE: lazoom #29523

Wrong! Government funding will help, as well as the Serum Institute of India!!!


BioClonetics is finalizing the production and testing of a monoclonal antibody to treat patients with HIV. HIV is a virus that infects 37 million and kills approximately 1.2 million every year, and today there is still no cure. At BioClonetics, we’ve created a cell line that produces fully human monoclonal antibodies to specifically target and neutralize infectious diseases including HIV. If successful, this could be the first true cure for HIV at a fraction of the price of current treatment.



https://icrowdnewswire.com/2017/05/19/invest-in-bioclonetics-immunotherapeutics/

BOOOOOOOM

$ENZC

bluebird50

10/07/20 9:19 AM

#29537 RE: lazoom #29523

Most medicines are.... why there’s so much money to be had in this field...

I was looking over your posting history the last 2 weeks.... I can tell when your in the stock! ;-)

Happy trading

lazoom

10/07/20 9:26 AM

#29545 RE: lazoom #29523

Just look at the cost no gov funding for this company but funding for others in this Field. The best they have going is a buy-out,so I'm waiting on the stop sign to come off and reconsider.